<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02016859</url>
  </required_header>
  <id_info>
    <org_study_id>IPF-2013-Rambam</org_study_id>
    <nct_id>NCT02016859</nct_id>
  </id_info>
  <brief_title>Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Yishai Ofran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that
      this value may be another prognostic factor in critically ill patients such as those admitted
      to ICU, or those with neutropenic Fever.

      The purpose of the study is to check if the IPF may be used as a prognostic Factor in these
      patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we have 3 groups of patients

        -  Patients admitted to ICU

        -  Patients admitted with neutropenic fever

        -  Patients admitted with hip fractures it is a prospective study, not interventional,
           we'll take blood samples of these patients including CBC count eith IPF and other
           inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical
           follow-up of the patient till discharge.

      At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these
      patients
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Time to recovery from sepsis or time to death</measure>
    <time_frame>6 months</time_frame>
    <description>the primary outcome is the result of the patient's admission on which data analysis will be based</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predicting value of IPF for prognosis</measure>
    <time_frame>baeline 6 months</time_frame>
    <description>after the analysis of the data we'll may ba able to assess the predicting value of the IPF in predicting severity of infection and prediciting prognosis of infection in the three groups described</description>
  </secondary_outcome>
  <other_outcome>
    <measure>clinical use of IPF as a prognostic factor</measure>
    <time_frame>up to 12 months</time_frame>
    <description>this outcome is not uet based we need much more studies in order to be able to use IPF in daily clinical work</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Critically Ill Patients</condition>
  <condition>Neutropenic Fever Patients</condition>
  <condition>Patients With Hip Fractures</condition>
  <arm_group>
    <arm_group_label>Critically ill patients admitted to ICU</arm_group_label>
    <description>those patients who are admitted to ICU with multiorgan failure/injury</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neutropinc Fever patients</arm_group_label>
    <description>admitted to ER, haemato-oncology or oncology</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients of Hip's Fracture</arm_group_label>
    <description>admitted to orthopedic departement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Immature Platelet Fraction</intervention_name>
    <arm_group_label>Critically ill patients admitted to ICU</arm_group_label>
    <arm_group_label>Neutropinc Fever patients</arm_group_label>
    <arm_group_label>Patients of Hip's Fracture</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        admmitted patients to multiple departements
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Admission to hospital blood sample is taken between 24:00 pm till 15:00 pm

        Exclusion Criteria:

          -  blood sample is taken after 15:00 pm in the first day of admission during the week

          -  blood sample is taken on weekend: thursday 15:00 pm till saturday 24:00 pm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yishai Ofran, Doctor</last_name>
    <phone>009720502061524</phone>
    <email>Y_ofran@ramabm.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Doaa Okasha, doctor</last_name>
    <phone>009720502062701</phone>
    <email>d_okasha@rambam.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rambam Health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>Di Mario A, Garzia M, Leone F, Arcangeli A, Pagano L, Zini G. Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. J Infect. 2009 Sep;59(3):201-6. doi: 10.1016/j.jinf.2009.07.007. Epub 2009 Jul 18.</citation>
    <PMID>19647322</PMID>
  </results_reference>
  <results_reference>
    <citation>De Blasi RA, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med. 2013 Apr;39(4):636-43. doi: 10.1007/s00134-012-2725-7. Epub 2012 Oct 24.</citation>
    <PMID>23093245</PMID>
  </results_reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2013</study_first_submitted>
  <study_first_submitted_qc>December 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2013</study_first_posted>
  <last_update_submitted>December 15, 2013</last_update_submitted>
  <last_update_submitted_qc>December 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Dr. Yishai Ofran</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>IPF Immature platelet fraction</keyword>
  <keyword>ICU neutropenic fever</keyword>
  <keyword>hip fracture</keyword>
  <keyword>critically ill</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

